Anz A, Branch E, Jordan S, Ostrander 3rd R, Kindle B, Presley J
Orthop J Sports Med. 2025; 13(3):23259671241312754.
PMID: 40052182
PMC: 11881934.
DOI: 10.1177/23259671241312754.
Liu S, Deng Z, Chen K, Jian S, Zhou F, Yang Y
Mol Med Rep. 2022; 25(3).
PMID: 35088882
PMC: 8809050.
DOI: 10.3892/mmr.2022.12615.
Zhan J, Yan Z, Kong X, Liu J, Lin Z, Qi W
J Cell Mol Med. 2021; 25(7):3573-3584.
PMID: 33751809
PMC: 8034440.
DOI: 10.1111/jcmm.16443.
Tseng C, Chen Y, Chang W, Tsai W, Ou T, Wu C
Int J Mol Sci. 2020; 21(3).
PMID: 32041125
PMC: 7038065.
DOI: 10.3390/ijms21031071.
Shin K, Cha Y, Ban Y, Seo D, Choi E, Park D
World J Stem Cells. 2019; 11(12):1115-1129.
PMID: 31875872
PMC: 6904861.
DOI: 10.4252/wjsc.v11.i12.1115.
Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system.
Yan K, Shen Y
Mol Med Rep. 2017; 16(4):3965-3973.
PMID: 28765966
PMC: 5646976.
DOI: 10.3892/mmr.2017.7110.
Oxygen tension modulates the effects of TNFα in compressed chondrocytes.
Tilwani R, Vessillier S, Pingguan-Murphy B, Lee D, Bader D, Chowdhury T
Inflamm Res. 2016; 66(1):49-58.
PMID: 27658702
PMC: 5209429.
DOI: 10.1007/s00011-016-0991-5.
Alterations in the Secretome of Clinically Relevant Preparations of Adipose-Derived Mesenchymal Stem Cells Cocultured with Hyaluronan.
Succar P, Breen E, Kuah D, Herbert B
Stem Cells Int. 2015; 2015:421253.
PMID: 26257790
PMC: 4518191.
DOI: 10.1155/2015/421253.
The regional sensitivity of chondrocyte gene expression to coactive mechanical load and exogenous TNF-α stimuli.
Bevill S, Boyer K, Andriacchi T
J Biomech Eng. 2014; 136(9):091005.
PMID: 24976081
PMC: 4112922.
DOI: 10.1115/1.4027937.
Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
Sengupta K, Krishnaraju A, Vishal A, Mishra A, Trimurtulu G, Sarma K
Int J Med Sci. 2010; 7(6):366-77.
PMID: 21060724
PMC: 2974165.
DOI: 10.7150/ijms.7.366.
High levels of Lymphotoxin-Beta (LT-Beta) gene expression in rheumatoid arthritis synovium: clinical and cytokine correlations.
ORourke K, ODonoghue G, Adams C, Mulcahy H, Molloy C, Silke C
Rheumatol Int. 2008; 28(10):979-86.
PMID: 18379788
DOI: 10.1007/s00296-008-0574-z.
Tumor necrosis factor-alpha in temporomandibular joint synovial fluid predicts treatment effects on pain by intra-articular glucocorticoid treatment.
Fredriksson L, Alstergren P, Kopp S
Mediators Inflamm. 2007; 2006(6):59425.
PMID: 17392588
PMC: 1775026.
DOI: 10.1155/MI/2006/59425.
Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?.
Buttle D, Bramwell H, Hollander A
Clin Mol Pathol. 1995; 48(4):M167-77.
PMID: 16696000
PMC: 407956.
DOI: 10.1136/mp.48.4.m167.
Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis.
Slot O, Brunner N, Locht H, Oxholm P, Stephens R
Ann Rheum Dis. 1999; 58(8):488-92.
PMID: 10419867
PMC: 1752924.
DOI: 10.1136/ard.58.8.488.
Exacerbation of antigen-induced arthritis in urokinase-deficient mice.
Busso N, Peclat V, van Ness K, Kolodziesczyk E, Degen J, Bugge T
J Clin Invest. 1998; 102(1):41-50.
PMID: 9649555
PMC: 509063.
DOI: 10.1172/JCI2312.
Urokinase in rheumatoid arthritis: causal or coincidental?.
Busso N, So A
Ann Rheum Dis. 1998; 56(12):705-6.
PMID: 9496148
PMC: 1752300.
DOI: 10.1136/ard.56.12.705.
Caprine arthritis encephalitis virus dysregulates the expression of cytokines in macrophages.
Lechner F, Machado J, Bertoni G, Seow H, Dobbelaere D, Peterhans E
J Virol. 1997; 71(10):7488-97.
PMID: 9311828
PMC: 192095.
DOI: 10.1128/JVI.71.10.7488-7497.1997.
Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.
Szekanecz Z, Haines G, Koch A
J Clin Pathol. 1997; 50(4):314-9.
PMID: 9215148
PMC: 499882.
DOI: 10.1136/jcp.50.4.314.
Ultrastructural analysis of mineralized matrix from human osteoblastic cells: effect of tumor necrosis factor-alpha.
Panagakos F, Fernandez C, Kumar S
Mol Cell Biochem. 1996; 158(1):81-9.
PMID: 8791288
DOI: 10.1007/BF00225886.
Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid.
Bendrups A, Hilton A, Meager A, Hamilton J
Rheumatol Int. 1993; 12(6):217-20.
PMID: 8484092
DOI: 10.1007/BF00301004.